Security key
29479A108
Erasca, Inc. - Common Stock, $0.0001 par value per share (ERAS)
CUSIP: 29479A108
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 232,039,374
- Total 13F value
- $633,439,326
- Share change
- +14,943,496
- Put/Call ratio
- 406%
- SEC-reported price per share
- $2.73
- Number of holders
- 130
- Value change
- +$46,910,487
- Number of buys
- 77
- Number of sells
- 45
- Shares outstanding
- 355,466,212
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
130
Top holders
10
ERAS full security history
Ownership snapshot
Full 13F holder table
Erasca, Inc. SEC filings
Erasca, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ERAS - Erasca, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Frazier Life Sciences Man...
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 4.6%
Showing 1-6 of 15 holder rows.
Quick read
Frazier Life Sciences Management, L.P. leads the comparable SEC ownership view at 4.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Frazier Life Sciences Management, L.P.'s linked filing trail.
Comparable ownership
Top 5
Frazier Life Sciences Management,...
4.6%
Venrock Adviser, LLC
4.6%
SUVRETTA CAPITAL MANAGEMENT, LLC
3.9%
ARCH Venture Management, LLC
3.1%
BlackRock Finance, Inc.
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
Company
|
4.6%
|
$38,270,270
16,216,216 shares
|
— | 30 Jun 2024 |
| Venrock Adviser, LLC |
13F
Company
|
4.6%
|
$38,270,270
16,216,216 shares
|
— | 30 Jun 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
Company
|
3.9%
|
$32,492,572
13,768,039 shares
|
— | 30 Jun 2024 |
| ARCH Venture Management, LLC |
13F
Company
|
3.1%
|
$26,091,107
11,055,554 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
3%
|
$25,042,777
10,611,346 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
2.9%
|
$24,430,120
10,351,746 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
130
Shares
232,039,374
Rows available
130
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
124
Q3 2024 holders
130
Holder diff
6
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|